Stephanie Combs (*1976) is a leading expert in the field of Radiation Oncology. The focus of her scientific expertise includes treatment optimization of brain and skull base tumors, tumors of the gastrointestinal tract, and tumors in the ear, nose, and throat. The development of new, highly precise radiation techniques and their early application in patient care are central to her research, including, for example, the personalized treatment of prostate tumors, breast cancer, and “oligometastatic” diseases. Her research includes technical developments as well as central work on biological therapy optimization in personalized radiation oncology.

She studied Medicine in Heidelberg, in Norfolk and San Antonio (USA). After receiving her doctorate in 2003, she worked as a Research Associate in Heidelberg. She habilitated in 2009 and became a Senior Physician at the Department of RadioOncology and Radiation Therapy at Heidelberg University Hospital in 2011. Only three years later, the TUM appointed Professor Combs to the professorship for Radiation Therapy. Since 2015, she has also headed the Institute of Radiation Medicine at Helmholtz Zentrum München. Since 2019, Professor Combs has also been Chair of the TUM Senate. At the University Hospital rechts der Isar, she heads the Oncology Center (OZ) and is Deputy Director of the Comprehensive Cancer Center Munich (CCCM) at the TUM site. Professor Combs is a member of national and international professional societies. Among others, she is a board member and spokesperson of the German Society of Radiation Oncology (DEGRO) and spokesperson of the Neurooncology Working Group (NOA) in the German Cancer Society (DKG). Her scientific work has been honored with the Herrmann Holthusen Prize of DEGRO, the Robert Janker Prize for Palliative Medicine, and the Translational Science Award of the American Society for Radiation Oncology (ASTRO), among others.